The treatment of deep venous thrombosis, including the newer agents

Disease-a-Month

Volumn 51, Issue 2-3, 2005, Pages 104-111

  Rectenwald, John E ^a   Wakefield, Thomas W ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; BLOOD CLOTTING FACTOR 10A INHIBITOR; CERTOPARIN; DALTEPARIN; FONDAPARINUX; HEPARIN; IDRAPARINUX; LOW MOLECULAR WEIGHT HEPARIN; MELAGATRAN; OXZAPARIN; TENZAPARIN; THROMBIN INHIBITOR; UNCLASSIFIED DRUG; WARFARIN; XIMELAGATRAN;

ALOPECIA; ANTICOAGULANT THERAPY; COMORBIDITY; DEEP VEIN THROMBOSIS; HEPARINIZATION; HUMAN; INCIDENCE; LUNG EMBOLISM; NONHUMAN; OSTEOPOROSIS; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; SKIN NECROSIS; THROMBOCYTOPENIA;

EID: 19444368059     PISSN: 00115029     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.disamonth.2005.03.004     Document Type: Article

References (30)

1. D.W. Barritt, S.C. J Anticoagulant drugs in the treatment of pulmonary embolism a controlled trial Lancet 1 1960 1309 1312
2. S.Z. Goldhaber, V.F. Tapson A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis Am J Cardiol 93 2 2004 259 262
3. A.G. van Den Belt, M.H. Prins, A.W. Lensing Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism Cochrane Database Syst Rev 2 2000 CD001100
4. W. Ageno, A.G. Turpie Low-molecular-weight heparin in the treatment of pulmonary embolism Semin Vasc Surg 13 3 2000 189 193
5. H.R. Buller, G. Agnelli, R.D. Hull Antithrombotic therapy for venous thromboembolic disease the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 suppl 3 2004 401S 428S
6. J.A. Caprini, C.J. Glase, C.B. Anderson Laboratory markers in the diagnosis of venous thromboembolism Circulation 109 12 suppl 1 2004 I4 I8
7. M.H. Meissner, M.T. Caps, R.O. Bergelin Early outcome after isolated calf vein thrombosis J Vasc Surg 26 5 1997 749 756
8. J.M. Lohr, T.M. Kerr, K.S. Lutter Lower extremity calf thrombosis to treat or not to treat? J Vasc Surg 14 5 1991 618 623
9. P.M. Ridker, S.Z. Goldhaber, E. Danielson Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism N Engl J Med 348 15 2003 1425 1434
10. C. Kearon, J.S. Ginsberg, M.J. Kovacs Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism N Engl J Med 349 7 2003 631 639
11. M.N. Levine, G. Raskob, R.J. Beyth Hemorrhagic complications of anticoagulant treatment the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 suppl 3 2004 287S 310S
12. J.I. Almeida, R. Coats, T.K. Liem Reduced morbidity and mortality rates of the heparin-induced thrombocytopenia syndrome J Vasc Surg 27 2 1998 309 314 discussion 315-6
13. A. Greinacher, I. Michels, C. Mueller-Eckhardt Heparin-associated thrombocytopenia the antibody is not heparin specific Thromb Haemost 67 5 1992 545 549
14. J. Laster, D. Silver Heparin-coated catheters and heparin-induced thrombocytopenia J Vasc Surg 7 5 1988 667 672
15. K.A. Bauer, F.R. Rosendaal, J.A. Heit Hypercoagulability too many tests, too much conflicting data Hematology (Am Soc Hematol Educ Program) 1 2002 35 68
16. B.M. Alving How I treat heparin-induced thrombocytopenia and thrombosis Blood 101 1 2003 31 37
17. A. Greinacher, H. Volpel, U. Janssens Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia a prospective study Circulation 99 1 1999 73 80
18. S.A. Mousa Low-molecular-weight heparin in thrombosis and cancer Semin Thromb Hemost 30 suppl 1 2004 25 30
19. P. Lopez-Beret, A. Orgaz, J. Fontcuberta Low molecular weight heparin versus oral anticoagulants in the long-term treatment of deep venous thrombosis J Vasc Surg 33 1 2001 77 90
20. A.Y. Lee, M.N. Levine, R.I. Baker Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer N Engl J Med 349 2 2003 146 153
21. C.J. van Dongen, M.R. Mac Gillavry, M.H. Prins Once versus twice daily LMWH for the initial treatment of venous thromboembolism Cochrane Database Syst Rev 1 2003 CD003074
22. H. Riess, K. Koppenhagen, A. Tolle Fixed-dose, body weight-independent subcutaneous low molecular weight heparin Certoparin compared with adjusted-dose intravenous unfractionated heparin in patients with proximal deep venous thrombosis Thromb Haemost 90 2 2003 252 259
23. S. Schulman, K. Wahlander, T. Lundstrom Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran N Engl J Med 349 18 2003 1713 1721
24. Investigators TM. The Matisse-DVT and PE trials J Thromb Haemost 1 suppl 1 2003 July: abstracts OC331, OC332.
25. H.R. Buller, B.L. Davidson, H. Decousus Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism N Engl J Med 349 18 2003 1695 1702
26. A.G. Turpie, K.A. Bauer, B.I. Eriksson Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery a meta-analysis of 4 randomized double-blind studies Arch Intern Med 162 16 2002 1833 1840
27. G. Agnelli, D. Bergquist, A. Cohen A randomized double-blind study to compare the efficacy and safety of fondaparinux with dalteparin in the prevention of venous thromboembolism after high-risk abdominal surgery the Pegasus Study J Thromb Haemost 1 suppl 1 2003 OC006
28. B.I. Eriksson, M.R. Lassen Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery a multicenter, randomized, placebo-controlled, double-blind study Arch Intern Med 163 11 2003 1337 1342
29. A.T. Cohen, A.S. Gallus, M.R. Lassen Fondaparinux vs placebo for the prevention of venous thromboembolism in acutely ill medical patients (artemis) J Thromb Haemost 1 suppl 2003 P2046
30. J.M. Herbert, J.P. Herault, A. Bernat Biochemical and pharmacological properties of SANORG 34006, a potent and long-acting synthetic pentasaccharide Blood 91 11 1998 4197 4205